Sunday, 29 March 2020

Japan News

  • Aveo, Astellas report cancer trial results

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2013

    Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, from the phase III TIVO-1 (Tivozanib versus sorafenib in first line adv...Read more

  • Top pharma deals in the last 5 years in APAC

    Japan |  Opinion | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    The number of mergers and acquisitions (M&A) that have been made over the past two years have almost returned to pre-downturn levels. This is in line with the recovery made by the pharm...Read more

  • Thailand, Japan collaborate on bioremediation

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jan, 2013

    Singapore: BIOTEC, NITE Biological Resource Center (NBRC) and Faculty of Science, Chulalongkorn University signed a project agreement to collaborate on "Assessment of microbial community...Read more

  • Japan, Singapore to bring innovation in drug, device, technology

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2013

    Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Science, Technology and Research (A*Star), the National University of Singa...Read more

  • Takeda enters into supply agreement for Omontys

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Takeda and Affymax, announced that Takeda Pharmaceuticals America (TPA) has entered into a supply agreement for sourcing and supply of Omontys (peginesatide) injection with DSI ...Read more

  • Japanese, Thai institutes sign bio-conservation MoU

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

    Singapore: A phase III memorandum of understanding (MoU) was signed between Thailand's BIOTEC and Japan's National Institute of Technology and Evaluation (NITE) on October 24, 2012, at the ...Read more

  • Takeda receives Japanese nod for Adcetris

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Jan, 2014

    Singapore: Japanese pharma major Takeda Pharma has announced that it has received approval of Adcetris (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare (MHLW)....Read more

  • Verastem enters research collaboration with Eisai

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jul, 2012

    Singapore: Verastem, a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced a research collabora...Read more

  • CRO INC Research expands to Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Therapeutically focused global clinical research organization, INC Research LLC has announced the establishment of INC Research Japan KK. The firm has opened in two new areas, Os...Read more

  • Sosei initiates oropharyngeal candidiasis trial

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Singapore: Sosei Group's Japanese subsidiary initiated a phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis. The study is an open-label, randomised, multiple centr...Read more

  • Japan study: Sugar solution makes tissue transparent

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Researchers from Japan's RIKEN Center for Developmental biology have developed a new sugar and water-based solution that turns tissues transparent in just three days, without dis...Read more

  • Astellas, Cytokinetics sign $490 mn muscle deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: US-based Cytokinetics and Japan-based Astellas Pharma entered in a two-year collaboration focused on the R&D and commercialization of skeletal muscle activators. The primary ...Read more

  • Astellas, XenoPort launch Regnite in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

    Singapore: Astellas Pharma and XenoPort have launched Regnite (gabapentin enacarbil) extended-release tablets. Regnite is approved in Japan for the treatment of moderate-to-severe primary r...Read more

  • TSRI, Takeda expand research collaboration

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

    Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collaboration to search for new drug targets for a variety of diseases. The...Read more

  • Japanese I'rom acquires 18% in Australian IDT

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange and is one of the leading providers of site manag...Read more

  • Iressa deaths: Japanese High Court rules in favor of AZ

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2012

    Singapore: The Japanese unit of AstraZeneca (AZ), has been acquitted, in a case that had held the firm responsible for the deaths of several individuals due to the side effects of the firm'...Read more

  • Asia vaccine strategists call for collaboration

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply for public health, and stronger partnership between international pl...Read more

  • Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand, to leverage and maximize the synergies of the Hybrid Business Model...Read more



Podcast

 

Survey Box

Are women in the industry getting the required recognition for their efforts?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls